Free Trial
→ No. 1 stock to cash in on the death of iPhone (From Stansberry Research) (Ad)tc pixel
NASDAQ:MRVI

Maravai LifeSciences Q3 2026 Earnings Date & Estimates

Maravai LifeSciences logo
$7.44 +0.23 (+3.19%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$7.45 +0.01 (+0.13%)
As of 10/9/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Maravai LifeSciences is expected to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for November 6, 2026 at 4:00 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
4:00 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Maravai LifeSciences in Q3 2026

Maravai LifeSciences is expected to post earnings of -$0.0563 per share on revenue of $43.56 million. In the same quarter a year earlier Maravai LifeSciences reported -$0.08 per share on revenue of $41.63 million. Maravai LifeSciences last reported on August 6, 2026, posting -$0.02 per share and beating the -$0.0435 consensus estimate. Maravai LifeSciences has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.0563
Expected Revenue
$43.56 million
Prior-Year EPS
-$0.08
Prior-Year Revenue
$41.63 million
Expected Revenue Growth
+4.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.02 (Beat by +$0.0235)
Last Quarter Revenue
$51.44 million
EPS Beat Rate
3 of last 8 quarters

Prepare for the Q3 2026 Call

Maravai LifeSciences Q3 2026 Earnings FAQ

Maravai LifeSciences (NASDAQ:MRVI) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Maravai LifeSciences' Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Maravai LifeSciences to post earnings of -$0.0563 per share for Q3 2026.

The consensus revenue estimate for Maravai LifeSciences is $43.56 million for Q3 2026.

Maravai LifeSciences Earnings Headlines

Maravai LifeSciences (NASDAQ:MRVI) Stock Moved Up to "Strong-Buy" by TD Cowen
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31091290
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Now Rated "Hold" by Wall Street Analysts
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31086646
Why I went to Mount Rushmore
A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel
October 10 at 1:00 AM  |  Stansberry Research (Ad)
Comparing Bullfrog AI (NASDAQ:BFRG) & Maravai LifeSciences (NASDAQ:MRVI)
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31086261
What Is Maravai’s (MRVI) Comeback Really Worth to Investors?
October 4, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/news/what-is-maravais-mrvi-comeback-really-worth-to-investors-1847835/
Maravai's TriLink Gets New China Patent for CleanCap Technology
September 29, 2026  |  marketscreener.comM
See More Maravai LifeSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Maravai LifeSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Maravai LifeSciences and other key companies, straight to your email.

About Maravai LifeSciences

Maravai LifeSciences (NASDAQ:MRVI) is a life sciences company that provides products and services used in the development and manufacture of biopharmaceuticals, vaccines, diagnostics and other advanced biological products. The company serves research, pharmaceutical, biotechnology and healthcare customers involved in nucleic acid production, biologics development and quality testing.

Maravai’s Nucleic Acid Production segment, which includes TriLink BioTechnologies, supplies specialized messenger RNA and other nucleic acid products, raw materials and related manufacturing services. These offerings support research and development as well as commercial applications such as mRNA-based medicines, vaccines, gene therapies and diagnostic products.

Through its Biologics Safety Testing segment, Maravai provides analytical services, reagents and testing products used to evaluate the safety, quality and purity of biologic products and their manufacturing processes. The company’s portfolio includes products and services for detecting contaminants and characterizing biological materials. Maravai was founded in 2014 and is headquartered in San Diego, California, serving customers in the United States and international markets through its operating companies and commercial relationships.

View Maravai LifeSciences Profile
Earnings Tools